GO:0010463 mesenchymal cell proliferation: Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0010463 mesenchymal cell proliferation describes the multiplication of mesenchymal cells, which are loosely organized cells that form three-dimensional masses rather than sheets.
• This process is essential for embryonic development, tissue repair, and fibrosis, and its dysregulation contributes to cleft palate, limb malformations, and cancer [1,6,7].
• Key regulatory mechanisms include growth factor signaling, microRNAs such as miR-214-3p, and intracellular proteins like Translin and IL-6 [5,6,8].
• Mesenchymal cell proliferation is studied using knockout, knock-in, and overexpression models, often combined with proliferation assays and lineage tracing [2,3,5].
• Gender and donor variability significantly affect mesenchymal stromal cell proliferation in vitro, impacting experimental reproducibility.
• CRISPR-based editing enables precise interrogation of genes controlling mesenchymal cell proliferation for disease modeling and therapeutic development [2,5].
Description
Mesenchymal cell proliferation (GO:0010463) is a fundamental biological process defined as the multiplication or reproduction of mesenchymal cells, leading to the expansion of a mesenchymal cell population. Mesenchymal cells are characterized by their ability to give rise to cells organized as three-dimensional masses rather than sheets, distinguishing them from epithelial cells. This process is critical during embryogenesis, where it drives the formation of connective tissues, skeletal elements, and organs, and in adults, where it supports tissue homeostasis and repair [1,5]. Dysregulated mesenchymal cell proliferation is a hallmark of numerous pathologies, including fibrosis, cleft palate, and cancer [1,6]. Understanding the molecular players and regulatory networks governing this process is therefore of broad biomedical importance. Recent research has identified diverse signaling pathways and intracellular factors that control mesenchymal cell proliferation. For instance, the RNA-binding protein Translin modulates both proliferation and differentiation of mesenchymal cells in mice. The cytokine IL-6 plays an intracellular role in mesenchymal stromal cell proliferation and immunosuppression. Additionally, environmental factors such as homocysteine and dioxin can perturb mesenchymal cell proliferation during chondrogenesis and palate development, respectively [6,7]. These findings highlight the sensitivity of this process to both genetic and environmental inputs. From a methodological standpoint, studying mesenchymal cell proliferation requires robust in vitro and in vivo models. Mesenchymal stromal cells (MSCs) are widely used, but their proliferation rates vary with donor gender and tissue source, necessitating careful experimental design. Advanced tools such as visualizable MSC-platelet hybrid cells and astrocyte-conditioned media models have been developed to track and manipulate proliferation in vivo [2,4]. This article synthesizes current knowledge on GO:0010463, covering its definition, mechanisms, key genes, disease relevance, and state-of-the-art research methods including CRISPR-based editing.
mesenchymal cell proliferation At A Glance
| GO ID | GO:0010463 |
|---|---|
| GO term | mesenchymal cell proliferation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Expansion of mesenchymal cell populations during development, tissue repair, and disease |
| Related processes | Mesenchymal cell differentiation, migration, and programmed cell death [1,5] |
| Key regulators | Translin, IL-6, miR-214-3p, homocysteine, dioxin [5,6,7,8] |
| Disease associations | Fibrosis, cleft palate, limb malformations, cancer [1,6,7] |
| Experimental models | MSC cultures, knockout mice, lineage tracing, hybrid cell systems [2,3,5] |
What Is GO:0010463?
GO:0010463 mesenchymal cell proliferation is the biological process by which mesenchymal cells multiply, resulting in an increased number of these cells. Mesenchymal cells are defined by their developmental potential to form three-dimensional cell masses, unlike epithelial cells that form sheets. This process is distinct from differentiation, although the two are often coordinated during tissue morphogenesis and repair [1,5].
Why Is mesenchymal cell proliferation Important in Cell Biology?
Mesenchymal cell proliferation is central to embryonic development and adult tissue homeostasis, and its dysregulation underlies a wide range of human diseases. In development, precise control of mesenchymal cell numbers is required for proper formation of the palate, limbs, and skeletal structures; perturbations lead to birth defects such as cleft palate [6,7]. In adults, excessive mesenchymal proliferation contributes to fibrosis in organs such as liver and lung, while insufficient proliferation impairs wound healing. Moreover, mesenchymal stromal cells are promising tools for regenerative medicine, and their therapeutic efficacy depends on controlled expansion [2,3]. Thus, understanding the mechanisms of GO:0010463 has direct implications for developmental biology, disease pathology, and cell-based therapies.
• Essential for embryonic development of skeletal, craniofacial, and connective tissues [1,5].
• Drives fibrosis in liver, lung, and kidney through excessive mesenchymal cell expansion.
• Implicated in cleft palate pathogenesis via environmental and genetic factors.
• Affects limb development and chondrogenesis; homocysteine disrupts this process.
• Critical for mesenchymal stromal cell-based therapies, where proliferation capacity determines efficacy [2,3].
• Regulated by microRNAs such as miR-214-3p, linking epigenetic control to developmental defects.
• Influenced by gender and donor variability, impacting reproducibility of MSC research.
• Modulated by intracellular IL-6, connecting inflammation to mesenchymal proliferation.
• Translin emerges as a key modulator of both proliferation and differentiation in mesenchymal cells.
• Astrocyte signaling can influence mesenchymal stem cell secretome effects on proliferation.
What Happens During mesenchymal cell proliferation?
Initiation by Growth Factors and Signaling
In simple terms: Mesenchymal cells start dividing when they receive growth signals from their environment.
Mesenchymal cell proliferation is initiated by extracellular cues such as growth factors, cytokines, and mechanical signals. For example, IL-6 can act intracellularly to promote mesenchymal stromal cell proliferation. In the developing limb, homocysteine exposure alters the normal proliferation of mesenchymal cells during chondrogenesis. Similarly, dioxin suppresses mesenchymal cell proliferation in the developing palate through miR-214-3p. These signals converge on cell cycle machinery to drive entry into S phase.
Cell Cycle Progression and DNA Replication
In simple terms: Once triggered, cells go through the cell cycle, copying their DNA and dividing.
After stimulation, mesenchymal cells progress through G1/S transition and complete DNA replication. The RNA-binding protein Translin modulates mesenchymal cell proliferation in mice, likely by regulating the stability or translation of mRNAs encoding cell cycle regulators. Disruption of Translin leads to altered proliferation and differentiation, indicating its role in coordinating these processes. The exact molecular targets of Translin in this context remain an active area of research.
Regulation by MicroRNAs and Epigenetic Factors
In simple terms: Small RNA molecules can fine-tune how fast mesenchymal cells divide.
MicroRNAs are key post-transcriptional regulators of mesenchymal cell proliferation. miR-214-3p mediates the suppressive effects of dioxin on mesenchymal cell proliferation and migration during cleft palate formation. This suggests that environmental toxicants can perturb proliferation by altering miRNA expression. Other miRNAs likely play similar roles, but their specific contributions require further study.
Coordination with Differentiation and Apoptosis
In simple terms: Proliferation is balanced with cell death and specialization to shape tissues.
Mesenchymal cell proliferation is tightly coordinated with programmed cell death and differentiation. In fibrogenesis, an imbalance between proliferation and apoptosis of mesenchymal cells leads to excessive matrix deposition. Translin modulates both proliferation and differentiation, indicating that these processes are linked. During limb development, homocysteine affects both proliferation and differentiation of mesenchymal cells, disrupting chondrogenesis. Thus, understanding proliferation requires considering its interplay with differentiation and death.
In Vivo Tracking and Functional Outcomes
In simple terms: Scientists can watch mesenchymal cells divide in living animals to see how they contribute to repair.
Advanced imaging and hybrid cell systems allow real-time tracking of mesenchymal cell proliferation in vivo. Visualizable mesenchymal stem cell-platelet hybrid cells have been used to treat intracerebral hemorrhage in models, where their proliferation is monitored. Astrocyte signaling can impact the effects of human bone marrow mesenchymal stem cell secretome on hippocampal astrocyte proliferation, demonstrating paracrine regulation. These approaches reveal how proliferation contributes to tissue regeneration and repair.
Key Genes Involved in GO:0010463 mesenchymal cell proliferation
The following genes and proteins have been experimentally implicated in the regulation of mesenchymal cell proliferation, as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Translin (TSN) | Modulates mesenchymal cell proliferation and differentiation in mice | Knockout studies show altered proliferation; potential target for developmental disorders |
| IL-6 | Intracellular role in mesenchymal stromal cell proliferation and immunosuppression | Knockdown or inhibition affects MSC expansion; relevant to inflammation and therapy |
| miR-214-3p | Mediates dioxin-induced suppression of mesenchymal cell proliferation and migration | Overexpression or inhibition in cleft palate models; biomarker for environmental exposure |
| Homocysteine (metabolic factor) | Disrupts mesenchymal cell proliferation during chondrogenesis | Exogenous administration in limb bud cultures; models for skeletal defects |
| Dioxin (TCDD) | Suppresses mesenchymal cell proliferation via miR-214-3p | Toxicological studies in palate development; gene-environment interaction |
| Astrocyte-derived factors | Impact mesenchymal stem cell secretome effects on proliferation | Co-culture and secretome experiments; neuroregeneration |
| MSC-platelet hybrid components | Enhance proliferation of visualizable mesenchymal stem cells | Hybrid cell generation for intracerebral hemorrhage treatment |
| Gender-related factors | Influence MSC proliferation and differentiation in vitro | Systematic review highlights donor gender as a variable |
| Programmed cell death regulators | Balance proliferation in fibrogenesis | Targets for anti-fibrotic therapy |
| Growth factor receptors | Initiate proliferative signaling in mesenchymal cells | General role inferred from context; specific receptors not detailed in cited papers |
| Cell cycle regulators (e.g., cyclins) | Drive progression through cell cycle | Downstream of Translin and IL-6; not directly cited but implied [5,8] |
| Extracellular matrix components | Provide niche signals for proliferation | Implicated in fibrosis and development |
| Transcription factors (e.g., Sox9) | Coordinate chondrogenic proliferation and differentiation | Not directly cited; context from homocysteine studies |
| Inflammatory cytokines | Modulate MSC proliferation | IL-6 is a key example |
| miRNA processing machinery | Required for miR-214-3p function | Inferred from dioxin studies |
| Platelet-derived factors | Enhance MSC proliferation in hybrid cells | Used in intracerebral hemorrhage models |
How Is mesenchymal cell proliferation Regulated?
Mesenchymal cell proliferation is regulated at multiple levels. Extracellular signals such as IL-6 can act intracellularly to promote proliferation of mesenchymal stromal cells. MicroRNAs, notably miR-214-3p, mediate suppressive effects of environmental toxicants like dioxin on proliferation. The RNA-binding protein Translin modulates proliferation and differentiation, likely through post-transcriptional regulation. Metabolic factors such as homocysteine can disrupt proliferation during chondrogenesis. Additionally, astrocyte-derived signals can influence mesenchymal stem cell secretome effects on proliferation. Gender and donor variability also affect MSC proliferation in vitro, highlighting the importance of intrinsic factors.
mesenchymal cell proliferation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| miR-214-3p | Cleft palate (dioxin-induced) | Knockout or overexpression in mouse palate mesenchymal cells |
| Translin (TSN) | Developmental defects (skeletal, growth) | Translin knockout mice; proliferation assays |
| IL-6 | Inflammation, fibrosis, impaired MSC therapy | IL-6 knockout or knockdown in MSCs; proliferation and immunosuppression assays |
| Homocysteine metabolism genes | Limb malformations, skeletal defects | Chick or mouse limb bud cultures with homocysteine |
| MSC-platelet hybrid factors | Intracerebral hemorrhage | Hybrid cell transplantation in rodent models |
Fibrosis and Tissue Remodeling
Dysregulated mesenchymal cell proliferation is a central feature of fibrogenesis. In conditions such as liver and lung fibrosis, excessive proliferation of mesenchymal cells, including myofibroblasts, leads to scarring and organ dysfunction. Targeting the balance between mesenchymal cell proliferation and programmed cell death is considered a therapeutic strategy for fibrosis.
Cleft Palate and Craniofacial Defects
Proper mesenchymal cell proliferation is essential for palate development. Environmental toxicants like dioxin suppress mesenchymal cell proliferation through miR-214-3p, contributing to cleft palate. This highlights gene-environment interactions in craniofacial birth defects.
Limb and Skeletal Malformations
During limb development, homocysteine disrupts mesenchymal cell proliferation and differentiation, impairing chondrogenesis. This can lead to skeletal abnormalities, demonstrating the importance of metabolic factors in developmental processes.
Regenerative Medicine and Cell Therapy
Mesenchymal stromal cells are used in regenerative medicine, and their therapeutic success depends on controlled proliferation. Enhanced proliferation of visualizable MSC-platelet hybrid cells improves treatment of intracerebral hemorrhage in preclinical models. Understanding gender effects on MSC proliferation is also critical for optimizing cell therapies.
From mesenchymal cell proliferation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate mesenchymal cell proliferation in vivo? | Knockout mouse (constitutive or conditional) with proliferation markers (Ki67, BrdU) |
| What is the effect of a point mutation in gene X on proliferation? | Point-mutation knock-in mouse or cell line; compare proliferation rates |
| Can we track mesenchymal cell proliferation in real time? | Knock-in of fluorescent reporter (e.g., GFP) under proliferation gene promoter; lineage tracing |
| Does overexpression of gene X enhance proliferation? | Overexpression vector or transgenic mouse; MSC cultures [2,8] |
| How does environmental exposure affect proliferation? | In vitro MSC cultures treated with dioxin or homocysteine; miRNA mimics/inhibitors [6,7] |
| Do gender differences affect MSC proliferation? | Primary MSCs from male and female donors; systematic comparison |
How to Study the mesenchymal cell proliferation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| BrdU/EdU incorporation | DNA synthesis (S phase entry) | Quantify proliferation in MSC cultures and tissues [3,5] |
| Ki67 immunostaining | Cells in active cell cycle | Assess proliferation in tissue sections |
| MTT assay | Metabolic activity as proxy for cell number | High-throughput screening of proliferation modulators |
| miRNA mimic/inhibitor transfection | Effect of specific miRNA on proliferation | Study miR-214-3p in cleft palate models |
| Knockout mouse models | Gene function in vivo | Translin, IL-6 studies [5,8] |
| Fluorescence imaging of hybrid cells | Real-time tracking of transplanted cells | Intracerebral hemorrhage treatment models |
| Secretome analysis | Paracrine effects on proliferation | Astrocyte-MSC co-culture studies |
| Systematic review/meta-analysis | Gender effects on MSC proliferation | Pooled analysis of donor variability |
Proliferation Assays
Common methods to measure mesenchymal cell proliferation include BrdU or EdU incorporation, Ki67 immunostaining, and MTT assays. These assays quantify DNA synthesis or metabolic activity and are widely used in MSC research [3,5]. For in vivo studies, BrdU pulse-chase labeling allows tracking of proliferating cells over time.
Genetic Knockout and Knockdown
Knockout mice and siRNA/shRNA knockdown are used to study gene function in mesenchymal cell proliferation. For example, Translin knockout mice exhibit altered proliferation and differentiation. IL-6 knockdown in MSCs affects their proliferation and immunosuppressive capacity. These approaches establish causality.
MicroRNA Modulation
miRNA mimics and inhibitors are used to manipulate miR-214-3p levels in mesenchymal cells. In dioxin-induced cleft palate models, miR-214-3p inhibition rescues proliferation defects. This method is valuable for studying post-transcriptional regulation.
Imaging and Lineage Tracing
Visualizable MSC-platelet hybrid cells enable tracking of proliferation in vivo using fluorescence imaging. Lineage tracing with Cre-lox systems can map the fate of proliferating mesenchymal cells during development and repair. These techniques provide spatial and temporal resolution.
How CRISPR Can Be Used to Study GO:0010463 mesenchymal cell proliferation
Knockout
CRISPR knockout of genes such as Translin or IL-6 in mesenchymal cells or mouse models can reveal their essential roles in proliferation. For example, Translin knockout mice show altered mesenchymal cell proliferation. Knockout of miR-214-3p target sites could also be used to study dioxin effects.
Point Mutation
Introducing point mutations in genes like Translin or IL-6 can dissect specific domains required for proliferation. For instance, mutating phosphorylation sites in IL-6 could test its intracellular role in MSC proliferation. Point mutations in miRNA binding sites can validate miR-214-3p regulation.
Knock-in
Knock-in of fluorescent reporters (e.g., GFP) under the control of proliferation-related gene promoters allows real-time visualization of mesenchymal cell proliferation. This approach has been used with MSC-platelet hybrid cells for tracking in intracerebral hemorrhage models. Knock-in of tagged proteins can also facilitate proteomic studies.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression of genes like IL-6 or miR-214-3p can enhance or suppress mesenchymal cell proliferation. Overexpression of miR-214-3p mimics dioxin effects, while inhibition rescues proliferation. Overexpression of Translin may increase proliferation, as suggested by knockout studies.
How EDITGENE Supports mesenchymal cell proliferation Research
Researchers studying mesenchymal cell proliferation-related genes often need to determine whether a candidate gene is causally involved in proliferation, differentiation, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for mesenchymal cell proliferation research.
Frequently Asked Questions About mesenchymal cell proliferation
What is GO:0010463 mesenchymal cell proliferation?
GO:0010463 is a Gene Ontology biological process term describing the multiplication of mesenchymal cells, leading to an expanded population of these cells, which form three-dimensional masses rather than sheets.
What genes are involved in mesenchymal cell proliferation?
Key genes include Translin (TSN), IL-6, and microRNA miR-214-3p, as well as metabolic factors like homocysteine [5,6,7,8].
How is mesenchymal cell proliferation regulated?
It is regulated by growth factors, cytokines like IL-6, microRNAs such as miR-214-3p, and RNA-binding proteins like Translin [5,6,8].
What diseases are associated with abnormal mesenchymal cell proliferation?
Fibrosis, cleft palate, limb malformations, and impaired regenerative capacity are linked to dysregulated mesenchymal cell proliferation [1,6,7].
How can I study mesenchymal cell proliferation in the lab?
Common methods include BrdU/EdU incorporation, Ki67 staining, MTT assays, and genetic models such as knockout mice or miRNA mimics [3,5,6].
What is the role of miR-214-3p in mesenchymal cell proliferation?
miR-214-3p mediates dioxin-induced suppression of mesenchymal cell proliferation and migration during cleft palate development.
Does gender affect mesenchymal stromal cell proliferation?
Yes, a systematic review found that donor gender significantly influences MSC proliferation and differentiation in vitro.
How does IL-6 affect mesenchymal stromal cell proliferation?
IL-6 acts intracellularly to promote mesenchymal stromal cell proliferation and immunosuppression.
What is the role of Translin in mesenchymal cell proliferation?
Translin modulates mesenchymal cell proliferation and differentiation in mice, as shown by knockout studies.
Can CRISPR be used to study mesenchymal cell proliferation?
Yes, CRISPR knockout, knock-in, point mutation, and overexpression models are powerful tools to dissect gene function in mesenchymal cell proliferation [2,5,6].
Conclusion
GO:0010463 mesenchymal cell proliferation is a critical biological process with broad implications for development, tissue repair, and disease. Key regulators such as Translin, IL-6, and miR-214-3p have been identified, and environmental factors like dioxin and homocysteine can disrupt this process, leading to birth defects and fibrosis [1,5,6,7,8]. Advances in CRISPR-based editing and in vivo imaging are accelerating our understanding of mesenchymal cell proliferation and enabling the development of targeted therapies [2,3]. Continued research into the molecular mechanisms and disease relevance of this process holds promise for regenerative medicine and the treatment of proliferative disorders.
References
- 1. Luna J et al.. 2011. Mesenchymal cell proliferation and programmed cell death: key players in fibrogenesis and new targets for therapeutic intervention.. Am J Physiol Gastrointest Liver Physiol 300(5):G703-8 PMID: 21233275
- 2. Wu G et al.. 2023. Enhanced Proliferation of Visualizable Mesenchymal Stem Cell-Platelet Hybrid Cell for Versatile Intracerebral Hemorrhage Treatment.. ACS Nano 17(8):7352-7365 PMID: 37037487
- 3. Vogt A et al.. 2024. The Effects of Gender on Mesenchymal Stromal Cell (MSC) Proliferation and Differentiation In Vitro: A Systematic Review.. Int J Mol Sci 25(24) PMID: 39769346
- 4. Campos J et al.. 2020. Astrocyte signaling impacts the effects of human bone marrow mesenchymal stem cells secretome application into the hippocampus: A proliferation and morphometrical analysis on astrocytic cell populations.. Brain Res 1732:146700 PMID: 32032613
- 5. Ikeuchi Y et al.. 2018. Translin modulates mesenchymal cell proliferation and differentiation in mice.. Biochem Biophys Res Commun 504(1):115-122 PMID: 30172368
- 6. Dong X et al.. 2025. 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Suppresses Mesenchymal Cell Proliferation and Migration Through miR-214-3p in Cleft Palate.. Cleft Palate Craniofac J 62(11):1930-1938 PMID: 39314083
- 7. Bourckhardt GF et al.. 2015. Effects of homocysteine on mesenchymal cell proliferation and differentiation during chondrogenesis on limb development.. J Appl Toxicol 35(11):1390-7 PMID: 25619733
- 8. Dorronsoro A et al.. 2020. Intracellular role of IL-6 in mesenchymal stromal cell immunosuppression and proliferation.. Sci Rep 10(1):21853 PMID: 33318571
